159 related articles for article (PubMed ID: 33633315)
41. Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression.
Yamaguchi K; Ariga T; Yamada M; Nelson DL; Kobayashi R; Kobayashi C; Noguchi Y; Ito Y; Katamura K; Nagatoshi Y; Kondo S; Katoh H; Sakiyama Y
Blood; 2002 Aug; 100(4):1208-14. PubMed ID: 12149199
[TBL] [Abstract][Full Text] [Related]
42. The genotype of the original Wiskott phenotype.
Binder V; Albert MH; Kabus M; Bertone M; Meindl A; Belohradsky BH
N Engl J Med; 2006 Oct; 355(17):1790-3. PubMed ID: 17065640
[TBL] [Abstract][Full Text] [Related]
43. A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ
Balashov D; Laberko A; Shcherbina A; Trakhtman P; Abramov D; Gutovskaya E; Kozlovskaya S; Shelikhova L; Novichkova G; Maschan M; Rumiantsev A; Maschan A
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1432-1440. PubMed ID: 29550630
[TBL] [Abstract][Full Text] [Related]
44. Impact of conditioning on outcome of hematopoietic stem cell transplantation for wiskott-Aldrich syndrome.
Stepensky P; Krauss A; Goldstein G; Zaidman I; Elhasid R; Bielorai B; Somech R; Or R; Stein J; Revel-Vilk S; Weintraub M
J Pediatr Hematol Oncol; 2013 Aug; 35(6):e234-8. PubMed ID: 23389496
[TBL] [Abstract][Full Text] [Related]
45. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
46. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
Thrasher AJ
Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
[TBL] [Abstract][Full Text] [Related]
47. Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome.
Shin CR; Kim MO; Li D; Bleesing JJ; Harris R; Mehta P; Jodele S; Jordan MB; Marsh RA; Davies SM; Filipovich AH
Bone Marrow Transplant; 2012 Nov; 47(11):1428-35. PubMed ID: 22426750
[TBL] [Abstract][Full Text] [Related]
48. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
Parkman R; Rappeport J; Geha R; Belli J; Cassady R; Levey R; Nathan DG; Rosen FS
N Engl J Med; 1978 Apr; 298(17):921-7. PubMed ID: 347289
[TBL] [Abstract][Full Text] [Related]
49. [HLA haploidentical hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: a case report and literatures review].
Ma H; Liu L; Xu S; Hu W; Zhang Y; Ma Y
Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):1027-9. PubMed ID: 25417886
[No Abstract] [Full Text] [Related]
50. Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma.
Tavil B; Erdem AY; Azik F; Isik P; Metin A; Emir S; Uckan D; Tunc B
Pediatr Transplant; 2013 Sep; 17(6):E146-8. PubMed ID: 23773507
[TBL] [Abstract][Full Text] [Related]
51. The Wiskott-Aldrich syndrome.
Ormerod AD
Int J Dermatol; 1985 Mar; 24(2):77-81. PubMed ID: 3886570
[No Abstract] [Full Text] [Related]
52. Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment.
Pai SY; Notarangelo LD
Immunol Allergy Clin North Am; 2010 May; 30(2):179-94. PubMed ID: 20493395
[TBL] [Abstract][Full Text] [Related]
53. Successful Reduced Intensity Conditioning Alternate Donor Stem Cell Transplant for Wiskott-Aldrich Syndrome.
Thakkar D; Katewa S; Rastogi N; Kohli S; Nivargi S; Yadav SP
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e493-e496. PubMed ID: 28859032
[TBL] [Abstract][Full Text] [Related]
54. Wiskott-Aldrich syndrome: new molecular and biochemical insights.
Peacocke M; Siminovitch KA
J Am Acad Dermatol; 1992 Oct; 27(4):507-19. PubMed ID: 1401301
[TBL] [Abstract][Full Text] [Related]
55. Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation.
Pai SY; DeMartiis D; Forino C; Cavagnini S; Lanfranchi A; Giliani S; Moratto D; Mazza C; Porta F; Imberti L; Notarangelo LD; Mazzolari E
Bone Marrow Transplant; 2006 Nov; 38(10):671-9. PubMed ID: 17013426
[TBL] [Abstract][Full Text] [Related]
56. Hematopoietic stem cell transplantation from a donor with Klinefelter syndrome for Wiskott-Aldrich syndrome.
Balci YI; Turul T; Daar G; Anak S; Devecioglu O; Tezcan I; Cetinkaya DU
Pediatr Transplant; 2008 Aug; 12(5):597-9. PubMed ID: 18331539
[TBL] [Abstract][Full Text] [Related]
57. Long-term outcome and chimerism in patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation: a retrospective nationwide survey.
Iguchi A; Cho Y; Yabe H; Kato S; Kato K; Hara J; Koh K; Takita J; Ishihara T; Inoue M; Imai K; Nakayama H; Hashii Y; Morimoto A; Atsuta Y; Morio T;
Int J Hematol; 2019 Sep; 110(3):364-369. PubMed ID: 31187438
[TBL] [Abstract][Full Text] [Related]
58. Progressive multifocal leukoencephalopathy after allogeneic bone marrow transplantation for Wiskott-Aldrich syndrome.
Yasuda Y; Yabe H; Inoue H; Shimizu T; Yabe M; Yogo Y; Kato S
Pediatr Int; 2008 Apr; 50(2):238-40. PubMed ID: 18353068
[No Abstract] [Full Text] [Related]
59. Successful allogeneic peripheral blood stem cell transplantation in Wiskott-Aldrich Syndrome Patients: first report in Thailand.
Hongeng S; Benjaponpitak S; Tardtong P; Varavithya W; Chuansumrit A; Chunharas A; Chaisiripoomkere W; Hathira P
Asian Pac J Allergy Immunol; 2001 Sep; 19(3):191-5. PubMed ID: 11826914
[TBL] [Abstract][Full Text] [Related]
60. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
